Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-124 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0639 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0784 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14 |
filingDate |
2011-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2017-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-101770785-B1 |
titleOfInvention |
Improved composition for inhibiting tumor cell proliferation |
abstract |
The present invention is directed to an inflammatory dendritic cell (DC) that stimulates x-vivo maturation by a specific treatment, a cancer immunotherapy that provides a method for such treatment and composition comprising said inflammatory DC. The DC may be used as a cell-based immunotherapy for inhibiting tumor cell proliferation. |
priorityDate |
2010-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |